デフォルト表紙
市場調査レポート
商品コード
1433614

In Vitro(体外)診断の世界市場規模、シェア、動向分析レポート:製品別、検査場所別、最終用途別、用途別、技術別、地域別、セグメント別予測(2024年~2030年)

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By End-use, By Application, By Technology, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
In Vitro(体外)診断の世界市場規模、シェア、動向分析レポート:製品別、検査場所別、最終用途別、用途別、技術別、地域別、セグメント別予測(2024年~2030年)
出版日: 2024年01月23日
発行: Grand View Research
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

In Vitro(体外)診断市場の成長と動向:

世界のIn Vitro(体外)診断の市場規模は、2030年までに1,015億8,000万米ドルに達すると予測されています。 高齢者人口の増加、COVID-19のパンデミック、診断の技術進歩が普及を後押ししており、予測期間のCAGRは4.4%です。

携帯性、正確性、費用対効果という点での技術進歩は、インパクトの大きい促進要因のひとつと予測されます。技術の進歩は、COVID-19 IVD診断薬の発売によってさらに加速され、PCRのような技術のための機器や消耗品の採用が強化されました。同市場における競合各社は、メーカーやユーザーにとってのビジネスの流れを一定に保つため、協定やパートナーシップ戦略を採用するようになってきています。

これらの協定はまた、政府のラボに対する厳しい価格抑制戦略の結果であり、政府の設定における価格を引き下げています。例えば、2021年4月、Seegene, Inc.のイタリア子会社は、715万件のSARS-CoV-2診断テストだけでなく、抽出試薬の供給のための公共調達のために1億825万米ドルの入札を受けました。SARS-CoV-2診断検査は、SARS-CoV-2診断検査とSARS-CoV-2抽出試薬の供給が主な目的ですが、サプライチェーンの多者間取引と複雑さが増します。がんと心血管疾患(CVDs)の世界の有病率の高さは、早期診断を促進し、消費者の絶え間なく進化するニーズに応えるための診断技術革新を促進すると予想されます。プラズモニックPCRのような新技術は、予測期間中に商業的に市場に参入し、既存製品のビジネスに悪影響を及ぼすと予想されます。

In Vitro(体外)診断市場レポートハイライト

  • 2024年~2030年のCAGRは、導入率と使用率の上昇により、分子診断が最速で成長すると見込まれます。
  • 遺伝子検査需要の急増と、アンメット・クリニカル・ニーズを抱える中低所得国における技術的に先進的な診断検査の利用可能性の向上により、試薬が最大の市場シェアを占めました。
  • 感染症用途分野は、世界的に大量の感染症検査が行われていることから、最大の市場シェアを占めています。
  • 2023年の世界市場は北米が支配的でしたが、これは新規技術に対する需要の高さ、主要企業の多さ、疾患の有病率の高さ、ヘルスケアのインフラの先進性によるものでした。

目次

第1章 In Vitro(体外)診断市場:調査手法と範囲

第2章 In Vitro(体外)診断用市場:市場の定義

第3章 In Vitro(体外)診断市場:エグゼクティブサマリー

  • 市場概要

第4章 In Vitro(体外)診断市場:製品の推定・動向分析

  • セグメントダッシュボード
  • In Vitro(体外)診断市場:製品の変動分析(2023年・2030年)
  • 機器
  • 試薬
  • サービス

第5章 In Vitro(体外)診断市場:技術の推定・動向分析

  • セグメントダッシュボード
  • In Vitro(体外)診断市場:技術の変動分析(2023年・2030年)
  • 免疫測定法
  • 血液学
  • 臨床化学
  • 分子診断学
  • 凝固
  • 微生物学
  • その他

第6章 In Vitro(体外)診断市場:用途の推定・動向分析

  • セグメントダッシュボード
  • In Vitro(体外)診断市場:用途の変動分析(2023年・2030年)
  • 感染症
  • 糖尿病
  • 腫瘍学/がん
  • 心臓病学
  • 腎臓学
  • 自己免疫疾患
  • 薬物検査
  • その他

第7章 In Vitro(体外)診断市場:検査場所の推定・動向分析

  • セグメントダッシュボード
  • In Vitro(体外)診断市場:検査場所の変動分析(2023年・2030年)
  • ポイントオブケア
  • 在宅ケア
  • その他

第8章 In Vitro(体外)診断市場:最終用途の推定・動向分析

  • セグメントダッシュボード
  • In Vitro(体外)診断市場:最終用途の変動分析(2023年・2030年)
  • 病院
  • ラボ
  • 在宅ケア
  • その他

第9章 In Vitro(体外)診断市場:地域の推定・動向分析

  • In Vitro(体外)診断市場シェア:地域別(2023年・2030年)
  • 北米
    • 北米のIn Vitro(体外)診断市場の推定・予測(2018年~2030年)
    • 米国
    • カナダ
  • 欧州
    • 欧州のIn Vitro(体外)診断市場の推定・予測(2018年~2030年)
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • デンマーク
    • ノルウェー
    • ロシア
  • アジア太平洋
    • アジア太平洋のIn Vitro(体外)診断市場の推定・予測(2018年~2030年)
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
    • シンガポール
  • ラテンアメリカ
    • ラテンアメリカのIn Vitro(体外)診断市場の推定・予測(2018年~2030年)
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカのIn Vitro(体外)診断市場の推定・予測(2018年~2030年)
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • クウェート

第10章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業の分類
  • 世界の企業の市場シェア分析(2023年)
  • 企業ヒートマップ分析
  • 戦略マッピング
    • 事業拡大
    • 合併と買収
    • パートナーシップとコラボレーション
    • 新製品の発売
    • 研究開発
  • 企業プロファイル
    • QIAGEN
    • BD
    • bioMerieux SA
    • F. Hoffmann-La Roche, Ltd.
    • QuidelOrtho Corporation
    • Abbott
    • Agilent Technologies, Inc.
    • Siemens Healthineers AG
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • Sysmex Corporation
    • Charles River Laboratories
    • Quest Diagnostics Incorporated
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global In Vitro Diagnostics Market, By Region, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million Number of instruments installed in thousands, Number of reagents sold in million
  • Table 5 Global In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 6 Global In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 7 Global In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 8 Global In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 10 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 11 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 12 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 13 North America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 14 North America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 19 U.S. In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 21 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 23 Canada In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 24 Canada In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 26 Europe In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 27 Europe In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 28 Europe In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 29 Europe In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 30 Europe In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 31 Europe In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 32 UK In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 33 UK In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 34 UK In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 35 UK In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 36 UK In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 37 Germany In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 38 Germany In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 39 Germany In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 40 Germany America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 41 Germany In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 42 France In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 43 France In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 44 France In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 45 France In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 46 France In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 47 Spain In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 48 Spain In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 49 Spain In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 50 Spain In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 51 Spain In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 52 Italy In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 53 Italy In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 54 Italy In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 55 Italy In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 56 Italy In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 57 Russia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 58 Russia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 59 Russia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 60 Russia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 61 Russia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 62 Asia Pacific In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 63 Asia Pacific In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 64 Asia Pacific In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 65 Asia Pacific In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 66 Asia-Pacific In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 67 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 68 China In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 69 China In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 70 China In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 71 China In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 72 China In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 73 Japan In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 74 Japan In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 75 Japan In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 76 Japan In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 77 Japan In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 78 India In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 79 India In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 80 India In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 81 India In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 82 India In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 83 South Korea In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 84 South Korea In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 85 South Korea In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 86 South Korea In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 87 South Korea In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 88 Singapore In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 89 Singapore In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 90 Singapore In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 91 Singapore In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 92 Singapore In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 93 Australia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 94 Australia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 95 Australia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 96 Australia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 97 Australia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 98 Latin America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 99 Latin America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 100 Latin America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 101 Latin America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 102 Latin America In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 103 Latin America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 104 Brazil In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 105 Brazil In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 106 Brazil In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 107 Brazil In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 108 Brazil In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 109 Mexico In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 110 Mexico In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 111 Mexico In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 112 Mexico In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 113 Mexico In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 114 Argentina In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 115 Argentina In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 116 Argentina In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 117 Argentina In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 118 Argentina In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 119 MEA In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 120 MEA In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 121 MEA In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 122 MEA In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 123 MEA In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 124 MEA In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 125 South Africa In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 126 South Africa In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 127 South Africa In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 128 South Africa In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 129 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 130 UAE In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 131 UAE In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 132 UAE In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 133 UAE In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 134 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million
  • Table 135 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 136 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 137 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 138 Saudi Arabia In Vitro Diagnostics Market, By End-use, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in
  • Table 139 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in million

List of Figures

  • Fig. 1 In Vitro Diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostic market snapshot
  • Fig. 10 Parent market outlook, 2023
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 In vitro diagnostic market driver impact
  • Fig. 13 Global population by age group, 2016 & 2027
  • Fig. 14 Global elderly population
  • Fig. 15 New cancer cases by year
  • Fig. 16 In vitro diagnostic market restraint impact
  • Fig. 17 Market entry strategy
  • Fig. 18 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 Consumer behavior analysis
  • Fig. 21 Strategy mapping
  • Fig. 22 IVD market: Product outlook and key takeaways
  • Fig. 23 IVD market: Products movement analysis
  • Fig. 24 Instruments market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands
  • Fig. 25 Reagents market estimates and forecast, 2018 - 2030 (USD Million), Number of reagents sold in millions
  • Fig. 26 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 IVD market: Technology outlook and key takeaways
  • Fig. 28 IVD Market: Technology movement analysis
  • Fig. 29 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 30 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Hematology market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 34 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Services market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 38 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 42 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Coagulation market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 46 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Microbiology market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 50 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Others market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 54 Instruments others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Reagents others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 IVD market: Application outlook and key takeaways
  • Fig. 58 IVD market: Application movement analysis
  • Fig. 59 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 IVD market: End-use outlook and key takeaways
  • Fig. 68 IVD treatment market: End-use movement analysis
  • Fig. 69 Hospitals market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 70 Laboratory market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 71 Home care market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 72 Other market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 73 IVD market: test location outlook and key takeaways
  • Fig. 74 IVD treatment market: Test location movement analysis
  • Fig. 75 Point-of-care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Homecare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 IVD Market: Regional outlook and key takeaways
  • Fig. 79 IVD market: Regional movement analysis
  • Fig. 80 North America
  • Fig. 81 North America, SWOT
  • Fig. 82 North America. market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 83 U.S. key country dynamics
  • Fig. 84 U.S. market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 85 Canada key country dynamics
  • Fig. 86 Canada market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 87 Europe
  • Fig. 88 Europe, SWOT
  • Fig. 89 Europe market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 90 UK key country dynamics
  • Fig. 91 UK market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 92 Germany key country dynamics
  • Fig. 93 Germany market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 94 Spain key country dynamics
  • Fig. 95 Spain market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 96 France key country dynamics
  • Fig. 97 France market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 98 Italy key country dynamics
  • Fig. 99 Italy market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 100 Russia key country dynamics
  • Fig. 101 Russia market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 102 Denmark key country dynamics
  • Fig. 103 Denmark market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 104 Sweden key country dynamics
  • Fig. 105 Sweden market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 106 Norway key country dynamics
  • Fig. 107 Norway market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 108 Asia Pacific
  • Fig. 109 Asia Pacific, SWOT
  • Fig. 110 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 111 Japan key country dynamics
  • Fig. 112 Japan market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 113 China key country dynamics
  • Fig. 114 China. market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 115 India key country dynamics
  • Fig. 116 India. market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 117 South Korea key country dynamics
  • Fig. 118 South Korea market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 119 Singapore key country dynamics
  • Fig. 120 Singapore market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 121 Thailand key country dynamics
  • Fig. 122 Thailand market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 123 Australia key country dynamics
  • Fig. 124 Australia market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 125 Latin America
  • Fig. 126 Latin America, SWOT
  • Fig. 127 Latin America market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 128 Brazil key country dynamics
  • Fig. 129 Brazil market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 130 Mexico key country dynamics
  • Fig. 131 Mexico market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 132 Argentina key country dynamics
  • Fig. 133 Argentina market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 134 Middle East & Africa
  • Fig. 135 Middle East & Africa, SWOT
  • Fig. 136 MEA market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 137 South Africa key country dynamics
  • Fig. 138 South Africa market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 139 United Arab Emirates key country dynamics
  • Fig. 140 United Arab Emirates market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 141 Saudi Arabia key country dynamics
  • Fig. 142 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million), Number of instruments installed in thousands, Number of reagents sold in millions
  • Fig. 143 Ansoff matrix
  • Fig. 144 Competition categorization
  • Fig. 145 Company market share analysis, 2023
  • Fig. 146 Global mass spectrometry company market share analysis, 2023
  • Fig. 147 North America mass spectrometry company market share analysis, 2023
  • Fig. 148 Europe mass spectrometry company market share analysis, 2023
  • Fig. 149 Asia Pacific mass spectrometry company market share analysis, 2023
  • Fig. 150 Global immunoassay company market share analysis, 2023
  • Fig. 151 North America immunoassay company market share analysis, 2023
  • Fig. 152 Europe immunoassay company market share analysis, 2023
  • Fig. 153 Asia Pacific immunoassay company market share analysis, 2023
  • Fig. 154 Global PCR company market share analysis, 2023
  • Fig. 155 North America PCR company market share analysis, 2023
  • Fig. 156 Europe PCR company market share analysis, 2023
  • Fig. 157 Asia Pacific PCR company market share analysis, 2023
  • Fig. 158 Company market position analysis
  • Fig. 159 Company market position analysis
  • Fig. 160 Company market position analysis
  • Fig. 161 Company profiles
  • Fig. 162 Regional network map
目次
Product Code: 978-1-68038-080-4

In Vitro Diagnostic Market Growth & Trends:

The global in vitro diagnostics market size is expected to reach USD 101.58 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 4.4% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights:

  • Molecular diagnostics is anticipated to grow at the fastest CAGR from 2024 to 2030 owing to the rising adoption and usage rate
  • Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs
  • The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally
  • North America dominated the global market in 2023 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure

Table of Contents

Chapter 1 In Vitro Diagnostics Market: Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
  • 1.12 List Of Abbreviations

Chapter 2 In Vitro Diagnostics Market: Market Definitions

Chapter 3 In Vitro Diagnostics Market: Executive Summary

  • 3.1 Market Summary

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In Vitro Diagnostics Market: Product Movement Analysis, USD Million, 2023 & 2030 (Volume Analysis)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests Sold)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, USD Million, 2023 & 2030 (Volume Analysis)
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Reagents
      • 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Services
      • 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Hematology
    • 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Services
      • 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Clinical Chemistry
    • 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. Services
      • 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. Services
      • 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Coagulation
    • 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.4. Services
      • 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Microbiology
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. Services
      • 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.9.4. Services
      • 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In Vitro Diagnostics Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 6.3. Infectious Disease
    • 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Diabetes
    • 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Oncology/Cancer
    • 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Cardiology
    • 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Nephrology
    • 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Drug Testing
    • 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, USD Million, 2023 & 2030
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Home-care
    • 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, USD Million, 2023 & 2030
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Laboratory
    • 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Home-care
    • 8.5.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. In Vitro Diagnostics Market Share, By Region, 2023 & 2030, USD Million
  • 9.2. North America
    • 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.3. Europe
    • 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.2. UK
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.3.10. Russia
      • 9.3.10.1. Key Country Dynamics
      • 9.3.10.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.10.3. Competitive Insights
      • 9.3.10.4. Russis In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.4.8. Singapore
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.8.3. Competitive Insights
      • 9.4.8.4. Singapore In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.5. Latin America
    • 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.3. Mexico
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.5.4. Argentina
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.4.3. Competitive Insights
      • 9.5.4.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2023
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. QIAGEN
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. BD
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. bioMerieux SA
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. F. Hoffmann-La Roche, Ltd.
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. QuidelOrtho Corporation
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. Abbott
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Agilent Technologies, Inc.
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. Siemens Healthineers AG
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Bio-Rad Laboratories, Inc.
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Danaher
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Sysmex Corporation
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments
    • 10.6.12. Charles River Laboratories
      • 10.6.12.1. Participant's Overview
      • 10.6.12.2. Financial Performance
      • 10.6.12.3. Product Benchmarking
      • 10.6.12.4. Recent Developments
    • 10.6.13. Quest Diagnostics Incorporated
      • 10.6.13.1. Participant's Overview
      • 10.6.13.2. Financial Performance
      • 10.6.13.3. Product Benchmarking
      • 10.6.13.4. Recent Developments